Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Jerusalem Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	11.74	6.59	7.73	5.44	1.96
Short-Term Investments	0.09	0.05	0.03	0.03	0.04
Trading Asset Securities	-	-	0.03	0.03	0.02
Cash & Short-Term Investments	11.84	6.64	7.79	5.49	2.02
Cash Growth	78.27%	-14.72%	41.69%	171.63%	67.77%
Accounts Receivable	28.25	29.95	31.63	30.81	24.2
Other Receivables	-	0	-	-	0.72
Receivables	28.25	29.95	31.63	30.81	24.92
Inventory	8.34	10.41	10.88	14.76	14.44
Prepaid Expenses	0.31	0.51	0.4	0.73	0.73
Other Current Assets	2.8	3.1	2.22	3.33	3.2
Total Current Assets	51.54	50.61	52.91	55.12	45.3
Property, Plant & Equipment	25.9	27.13	25.48	27.47	27.15
Long-Term Investments	7.24	6.42	3.22	0.7	1.22
Other Intangible Assets	1.8	1.55	1.52	3.04	3.53
Long-Term Deferred Tax Assets	0.4	0.28	0.27	0.2	0.16
Other Long-Term Assets	2.27	0.32	0.32	0.37	0.36
Total Assets	89.15	86.32	83.72	86.89	77.71
Accounts Payable	3.29	3.48	6.56	5.11	4.35
Accrued Expenses	3.58	2.33	1.32	1.99	1.39
Short-Term Debt	0.46	0.52	0.65	0.78	1.69
Current Portion of Long-Term Debt	0.61	1.13	0.69	0.57	0.6
Current Portion of Leases	0.3	0.48	0.36	0.55	0.64
Current Income Taxes Payable	1.29	2.42	2.67	1.66	0.18
Other Current Liabilities	2.46	1.95	1.46	2.3	2
Total Current Liabilities	12	12.32	13.7	12.97	10.84
Long-Term Debt	-	-	-	-	0.38
Long-Term Leases	0.14	0.33	0.49	0.72	0.55
Long-Term Unearned Revenue	0.29	-	-	-	-
Total Liabilities	17.55	17.44	18.49	18.32	16.07
Common Stock	18	18	18	18	18
Additional Paid-In Capital	3.72	3.72	3.72	3.72	3.72
Retained Earnings	42.83	39.6	34.9	29.89	24.73
Comprehensive Income & Other	6.04	6.52	7.65	14.87	12.87
Total Common Equity	70.6	67.84	64.27	66.47	59.32
Minority Interest	1.01	1.04	0.96	2.1	2.32
Shareholders' Equity	71.61	68.88	65.23	68.57	61.64
Total Liabilities & Equity	89.15	86.32	83.72	86.89	77.71
Total Debt	1.51	2.47	2.18	2.63	3.85
Net Cash (Debt)	10.32	4.17	5.6	2.86	-1.83
Net Cash Growth	147.75%	-25.64%	95.69%	-	-
Net Cash Per Share	0.57	0.23	0.31	0.16	-0.10
Filing Date Shares Outstanding	18	18	18	18	18
Total Common Shares Outstanding	18	18	18	18	18
Working Capital	39.53	38.28	39.2	42.16	34.46
Book Value Per Share	3.92	3.77	3.57	3.69	3.30
Tangible Book Value	68.8	66.29	62.75	63.43	55.8
Tangible Book Value Per Share	3.82	3.68	3.49	3.52	3.10
Land	9.49	10.63	9.24	8.31	8.13
Buildings	15.42	15.64	15.73	16.34	15.87
Machinery	30.8	29.47	28.78	31.82	29.69

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.